The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity

被引:254
作者
Girod, A
Wobus, CE
Zádori, Z
Ried, M
Leike, K
Tijssen, P
Kleinschmidt, JA
Hallek, M
机构
[1] Univ Munich, Genzentrum, Mol Biol Lab, D-81377 Munich, Germany
[2] Deutsch Krebsforschungszentrum, Forschungsschwerpunkt Angew Tumorvirol, D-69120 Heidelberg, Germany
[3] Univ Quebec, Inst Armand Frappier, INRS, Ctr Microbiol & Biotechnol, Laval, PQ H7V 1B7, Canada
[4] Univ Munich, Klinikum Grosshadern, Med Klin 3, D-81377 Munich, Germany
[5] GSF, Natl Res Ctr Environm & Hlth, Klin Kooperat Grp Gentherapie, D-81377 Munich, Germany
关键词
D O I
10.1099/0022-1317-83-5-973
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The unique region of the VP1 protein of parvoviruses was proposed to contain a parvoviral phospholipase A2 (pvPLA2) motif. Here, PLA2 activity is shown in the unique region of adeno-associated virus type 2 (AAV-2) VP1 when expressed as an isolated domain in bacteria. Mutations in this region of the capsid protein strongly reduced the infectivity of mutant virions in comparison to wild-type AAV-2. This correlated with effects on the activity of PLA2. The mutations had no influence on capsid assembly, packaging of viral genomes into particles or binding to and entry into HeLa cells. However, a delayed onset and reduced amount of early gene expression, as measured by Rep immunofluorescence, was observed. These results suggest that pvPLA2 activity is required for a step following perinuclear accumulation of virions but prior to early gene expression.
引用
收藏
页码:973 / 978
页数:6
相关论文
共 18 条
  • [1] Regulation and inhibition of phospholipase A2
    Balsinde, J
    Balboa, MA
    Insel, PA
    Dennis, EA
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 175 - 189
  • [2] PARVOVIRUS REPLICATION
    BERNS, KI
    [J]. MICROBIOLOGICAL REVIEWS, 1990, 54 (03) : 316 - 329
  • [3] Berns KI, 1996, CURR TOP MICROBIOL, V218, P1
  • [4] The growing phospholipase A(2) superfamily of signal transduction enzymes
    Dennis, EA
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (01) : 1 - 2
  • [5] Phospholipase A2 enzymes:: structural diversity in lipid messenger metabolism
    Dessen, A
    [J]. STRUCTURE WITH FOLDING & DESIGN, 2000, 8 (02): : R15 - R22
  • [6] Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
    Girod, A
    Ried, M
    Wobus, C
    Lahm, H
    Leike, K
    Kleinschmidt, J
    Deléage, G
    Hallek, M
    [J]. NATURE MEDICINE, 1999, 5 (09) : 1052 - 1056
  • [7] Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2
    Grimm, D
    Kern, A
    Pawlita, M
    Ferrari, FK
    Samulski, RJ
    Kleinschmidt, JA
    [J]. GENE THERAPY, 1999, 6 (07) : 1322 - 1330
  • [8] GENETICS OF ADENO-ASSOCIATED VIRUS - ISOLATION AND PRELIMINARY CHARACTERIZATION OF ADENO-ASSOCIATED VIRUS TYPE-2 MUTANTS
    HERMONAT, PL
    LABOW, MA
    WRIGHT, R
    BERNS, KI
    MUZYCZKA, N
    [J]. JOURNAL OF VIROLOGY, 1984, 51 (02) : 329 - 339
  • [9] MAJOR PROTEINS OF BOVINE SEMINAL PLASMA INHIBIT PHOSPHOLIPASE A(2)
    MANJUNATH, P
    SOUBEYRAND, S
    CHANDONNET, L
    ROBERTS, KD
    [J]. BIOCHEMICAL JOURNAL, 1994, 303 : 121 - 128
  • [10] Regulatory functions of phospholipase A(2)
    Murakami, M
    Nakatani, Y
    Atsumi, G
    Inoue, K
    Kudo, I
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 1997, 17 (3-4) : 225 - 283